MANAGEMENT OF CIN 1

Risk of follow up of CIN 1 -

1. Invasive cancer already exists and was missed by Pap, colpo and biopsy.

2. Invasive cancer develops between follow up visits.

3. Patient lost to follow up and develops invasive cancer.

Previous slide

Next slide

Back to first slide

View graphic version